BIOL

Biolase, Inc.
BIOL

Overview Fund Activity
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

18 hedge funds and large institutions have $8.65M invested in Biolase, Inc. in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 10 closing their positions.

Holders
18
Holders Change
-8
Holders Change %
-30.77%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
4
Reduced
6
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PCM
1
Princeton Capital Management
New Jersey
$36K
2
TSS
2
Two Sigma Securities
New York
$15K
3
Northern Trust
3
Northern Trust
Illinois
$39K
4
BlackRock
4
BlackRock
New York
$348K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$356K

Top Sellers

1
TMC
1
Trellus Management Company
Florida
$0
2
BC
2
Birchview Capital
Vermont
$165K
3
TA
3
Teton Advisors
New York
$36K
4
GF
4
Gabelli Funds
New York
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
WS
26
Wedbush Securities
California
– -$4K -1 Closed
Lido Advisors
27
Lido Advisors
California
– -$5K -1 Closed
USAA
28
United Services Automobile Association
Texas
– -$5K -1 Closed
FDCDDQ
29
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$1 – –
1
2